FMBA has set the timeframe for the start of the use of the Russian cancer vaccine
An advanced domestic cancer drug will be used as early as 2025.
The medicine was developed by experts from the Federal Medical and Biological Agency (FMBA).
The head of the agency, Veronika Skvortsova, spoke about the timing of the start of using the drug, TASS reports.
During a meeting with the Russian President, she reported that FMBA experts had completed a three-year drug testing cycle.
The agency's specialists plan to begin using the drug to treat cancer patients in 2025.
Russian scientists have created a personalized remedy that can be used to treat different types of cancer.
Domestic specialists have developed a unique technology that allows for the verification of mutations that cause tumors.
For reference
FMBA is a federal executive body that exercises functions on legal regulation in the field of medical and sanitary provision.
